Skip to main content
. 2015 Oct-Dec;4(4):222–225. doi: 10.4103/2279-042X.167047

Table 3.

Distribution of appropriate use of meropenem based on DUE criteria (n=100)

graphic file with name JRPP-4-222-g003.jpg